The US Food and Drug Administration (USFDA) has successfully completed the inspection at Dishman Carbogen Amcis’ Naroda facility in Ahmedabad on February 15, 2019. The inspection was concluded without any observations or Form 483's.
Thus, the Company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the USFDA.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.
